Global E-Health Forum to Present Strategies, Solutions and Services

25 - 26 October 2010, Hamburg, Germany.
Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic diseases and expensive treatments, to mention some of the most important ones. The Global E-Health Forum will addresses these challenges. The first conference day at the Hamburg Chamber of Commerce will feature strategy and best practice presentation, workshops, discussion forums and an accompanying exhibition. The second day will be hosted by Asklepios Clinics. There, conference attendees may expect show cases, hands-on presentations and guided tours as well as a panel discussion titled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver". The official reception for the international audience will take place at the U.S. Consulate General.

"Countries all over the world are facing manifold challenges regarding their healthcare delivery. Due to limited budgets and increasing demand for high-quality healthcare services, new cost-efficient, reliable and interconnected systems need to be developed", explains Ljubisav Matejevic, founder and director of the Global E-Health Forum. "This is the reason why after three Baltic Conferences on E-Health (2007-2009), we have decided to found the Global E-Health Forum," continues Ljubisav Matejevic. "E-health, meaning the application of information and communication technologies across the whole range of functions that affect the health sector, can make an important contribution to ensure a high-quality healthcare service for all citizens now and in the future.”

In keynote presentations, speakers from the U.S., Europe and New Zealand will explain their e-health strategies. Harry Reynolds, chairman of the National Committee on Vital and Health Statistics (NCVHS) and chairman of the Council for Affordable Quality Healthcare (CAQH) CORE Initiative will start this program session with his presentation titled "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The second program session will deal with best practices, for example presenting the hospital information system of Severance Cardiovascular Hospital in Seoul, South Korea. Other best practices featured will be a medical decision support system for general practitioners and interesting solutions regarding questions of quality management and process optimization.

The program will also include various breakout sessions with workshops and discussion forums where e.g. sustainable telemedicine services will be presented.

The organizers of the Global E-Health Forum - European Health Telematics Association (EHTEL), Hamburg Chamber of Commerce and IBM - have identified in Asklepios an excellent cooperation partner. Recognized as one of the most innovative leading hospital chains (the group oversees over 100 institutions, almost 40 day clinics, around 22,000 beds and 36,000 staff in Germany, Europe and the USA), Asklepios takes care of over one million patients every year. At Asklepios Clinics in Hamburg, attendees may expect more best practice solutions and hands-on experience. However, another important part will be the "services session" meaning the patients' and consumers' perspective / patient-centric e-health services. Uwe Poettgen, CIO of the Asklepios Group, will introduce this topic with a presentation entitled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver".

The primary aim of the English-language conference is to provide a cross-sector forum for approximately 200 representatives from hospitals and clinics, governments, health insurance organizations, service providers and the media. Policymakers, users, suppliers and implementation managers will have the opportunity to exchange views and experiences among all those involved in health management. The impact of globalization on healthcare systems and services will be discussed as well as the resulting requirements regarding interconnectivity, interoperability and standardization as well as the need for cross border co-operation.

Among the supporters of this year's conference are the European Association of Healthcare IT Managers, Koch-Mechnikov-Forum, German Hospital Society, U.S. Commercial Service, Finpro, Business Institute (Croatia), and FOM University of Applied Sciences.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Cannabis extract helps reset brain function in psy…

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psyc...

For first time in 40 years, cure for acute leukemi…

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has been no encouraging news for most leukemi...

New cancer treatment uses enzymes to boost immune …

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill can...

Bayer accelerates six new startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies fr...

Novartis receives European Commission approval of …

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pe...

Shire completes sale of oncology franchise

Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the...

Antioxidant reduces risk for second heart attack, …

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the A...

Novartis to divest the Sandoz US dermatology busin…

Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids po...

SOLAR-1 trial of Novartis investigational alpha-sp…

Novartis today announced the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) has met the primary endpoint s...

New tablet production facility in Ingelheim: Cente…

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on ...

Tezepelumab granted Breakthrough Therapy Designati…

AstraZeneca and its partner Amgen Inc. (Amgen) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab...

Pfizer terminates domagrozumab (PF-06252616) clini…

Pfizer Inc. (NYSE: PFE) announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrop...